AcquisitionOther
Peak Bio, Inc. acquired Akari Therapeutics, Plc, a public company limited by shares
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Peak Bio, Inc. -> Akari Therapeutics, Plc, a public company limited by shares · $3.2 million
(the “Company”) completed the previously announced strategic combination (the “Closing”) contemplated by the Agreement and Plan of Merger by and among the Company, Akari Therapeutics, Plc, a public company limited by shares under the laws of England and Wales
Open source record (SEC) ↗